ArticleOPEN ACCESS

Vedolizumab as induction and maintenance therapy for Crohn's disease: Commentary

Inflammatory Bowel Disease Monitor
ISSN: 14667401
10Citations
Citations of this article
1.3kReaders
Mendeley users who have this article in their library.

Cite

CITATION STYLE

APA

Balzola, F., Cullen, G., Ho, G. T., & Russell, R. (2014). Vedolizumab as induction and maintenance therapy for Crohn’s disease: Commentary. Inflammatory Bowel Disease Monitor. Remedica Medical Education and Publishing.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free